MarketResearchReports.biz has added a new research report to its repository. The report, titled “Global Transplant Diagnostics 2016-2020”, offers a comprehensive study on the global transplant diagnostics market and states the key factors affecting the growth of the market. The report projects the global transplant diagnostics market to expand at a CAGR of 6.63% during the period between 2016 and 2020. The market has been studied on the basis of screening, products, applications, and regions. Furthermore, the report profiles some of the key players in the global transplant diagnostics market.
Transplantation involves the transfer of organs, tissues, or cells from a donor to a recipient for restoring a particular function of the body in case of damage. The organs, tissues, and cells of a donor and a recipient need to match or be compatible as incompatibility will lead to transplant rejection in the recipient’s body. The Human Leukocyte Antigens (HLAs) regulate body recognition and reject foreign tissue transplants. The compatibility between the donor and recipient is ensured by major histocompatibility complex, controlled by the genes located on chromosome 6.
According to the report, the growing awareness about organ donation has boosted the growth of the global transplant diagnostics market. Various private and government organizations are conducting awareness programs to spread the knowledge about organ transplantation. However, limited technical expertise might restrain the market’s growth during the forecast period. The overall market has a significant opportunity to grow with the introduction of new transplant diagnostics approved by regulatory authorities such as the U.S. FDA.
On the basis of screening, the report segments the global transplant diagnostics market into pre- and post-transplant diagnostics. The post-transplant diagnostics segment dominated the overall market in 2015 and held over 59% of the market. Recipients usually undergo regular biopsies after organ transplantation and hence, the demand for post-transplant diagnostics is high.
The report studies the global transplant diagnostics market across three key regions: the Americas, EMEA, and APAC. During the forecast horizon, the Americas is anticipated to dominate the overall market with a share of 53% share. The rapid growth of the regional market can be attributed to the rising procurement of transplant diagnostic instruments by various medical facilities.
Describing the competitive landscape, the report profiles some of the key players in the global transplant diagnostics market such as CareDx, Bio-Rad Laboratories, Immucor, Illumina, Thermo Fisher Scientific, Linkage Biosciences, Sigma-Aldrich, Siemens, Tosoh Bioscience, Oxford Immunotec, Qiagen, Ortho Clinical Diagnostics, Danaher, Abbott Laboratories, HistoGenetics, F. Hoffmann - La Roche, and Becton Dickinson & Co. The report provides detailed information about the key players including their company overview, financial overview, revenue, business strategies, and recent developments. A number of market players are shifting their operations to APAC due to significant growth opportunities in the region. Furthermore, the vendors are partnering with hospitals and transplant centers to expand their reach.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org